Rx For Industry: Key Provisions Of The 21st Century Cures Act

Changes to the priority review voucher program, economic communications with payors, and approval of antimicrobial products all have the potential to impact the commercial prospects of drugmakers.

The roller-coaster ride of the 21st Century Cures Act is nearly complete, with the Senate voting 94-5 in favor on Dec. 7 in favor of the measure. It now moves on to President Obama, who said he will "sign it as soon as it reaches my desk."

More from Anti-infective

More from Therapy Areas